Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Intimation Of Board Meeting Of The Company To Be Held On Friday, The September 02, 2022

 With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the September 02, 2022 at 12:30 p.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): 1) To consider declaration of Interim Dividend for the financial year 2022-23 and related matters etc. and 2) Advance intimation under regulation 42: The Record Date for the purpose of payment of interim dividend to eligible shareholders would be September 12, 2022, if considered and approved by the Board.
29-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Corporate Action-Board to consider Dividend

 With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the September 02, 2022 at 12:30 p.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): 1) To consider declaration of Interim Dividend for the financial year 2022-23 and related matters etc. and 2) Advance intimation under regulation 42: The Record Date for the purpose of payment of interim dividend to eligible shareholders would be September 12, 2022, if considered and approved by the Board. Please further note that TRADING WINDOW for dealing in the securities of the company will be closed from August 30, 2022 as per PIT Code of the Company. Trading window will be opened from September 05, 2022.
29-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Friday, The September 02, 2022

 Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2022 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Friday, the September 02, 2022 at 12:30 p.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): 1) To consider declaration of Interim Dividend for the financial year 2022-23 and related matters etc. and 2) Advance intimation under regulation 42: The Record Date for the purpose of payment of interim dividend to eligible shareholders would be September 12, 2022, if considered and approved by the Board. Please further note that TRADING WINDOW for dealing in the securities of the company will be closed from August 30, 2022 as per PIT Code of the Company. Trading window will be opened from September 05, 2022.
29-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Suven Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
19-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 This is with reference to our earlier letter dated July 26, 2022 regarding the 4th Annual General Meeting (AGM) of the Company held today i.e. August 18, 2022 and the businesses mentioned in the Notice dated May 9, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
18-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is with reference to our earlier letter dated July 26, 2022 regarding the 4th Annual General Meeting (AGM) of the Company held today i.e. August 18, 2022 and the businesses mentioned in the Notice dated May 9, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
18-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on August 8, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.
16-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Financial Results of the Company for the quarter ended June 30, 2022. The advertisements as appeared today i.e. August 9, 2022 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements This is for your information and record.
09-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated August 4, 2022, that audio recording of the conference call for the quarter ended June 30, 2022 held on Monday, August 8, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release In view of the above, please further note that Trading Window will be opened from 11th August, 2022 instead of 13th August, 2022 as intimated earlier through our Notice of Board Meeting dated 1st August, 2022. This is for your information and record.
09-08-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - General Updates

 With reference to the above subject, the Board of Directors of the company, at its meeting held on August 08, 2022, took note of the letter reference No. SOP-Review-(20-May-2022) received from BSE and NSE/LIST-SOP/COMB/FINES/0823, dated May 20, 2022 received from NSE in the matter of non-compliance identified with respect to Regulation 19 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and given below comments:
09-08-2022
Next Page
Close

Let's Open Free Demat Account